Get the Stockscreener App
121.48
3.43%
-4.32
After Hours:
121.00
-0.48
-0.40%
Abivax Adr stock is traded at $121.48, with a volume of 984.84K.
It is down -3.43% in the last 24 hours and up +5.18% over the past month.
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
See More
Previous Close:
$125.80
Open:
$126.5
24h Volume:
984.84K
Relative Volume:
0.91
Market Cap:
$9.63B
Revenue:
-
Net Income/Loss:
$-190.65M
P/E Ratio:
-22.47
EPS:
-5.4062
Net Cash Flow:
$-166.96M
1W Performance:
+2.12%
1M Performance:
+5.18%
6M Performance:
+27.06%
1Y Performance:
+1,905%
1-Day Range:
$119.50
$126.80
1-Week Range:
$119.50
$128.42
52-Week Range:
$5.59
$148.83
Abivax Adr Stock (ABVX) Company Profile
Compare ABVX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABVX
Abivax Adr
|
121.48 | 9.97B | 0 | -190.65M | -166.96M | -5.4062 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-16-26 | Initiated | Jefferies | Buy |
| Feb-24-26 | Initiated | Wedbush | Outperform |
| Nov-24-25 | Initiated | Truist | Buy |
| Nov-06-25 | Initiated | Wolfe Research | Outperform |
| Oct-13-25 | Initiated | Barclays | Overweight |
| Jul-23-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-25 | Initiated | Morgan Stanley | Equal-Weight |
| Dec-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jul-29-24 | Initiated | Laidlaw | Buy |
| May-20-24 | Initiated | BTIG Research | Buy |
| Apr-29-24 | Initiated | Guggenheim | Buy |
| Apr-29-24 | Initiated | Piper Sandler | Overweight |
| Nov-14-23 | Initiated | Leerink Partners | Outperform |
| Nov-14-23 | Initiated | Morgan Stanley | Equal-Weight |
View All
Abivax Adr Stock (ABVX) Latest News
Tudor Investment Corp ET AL Buys New Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Crohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032 - GlobeNewswire Inc.
Why Abivax SA Sponsored ADR Shares Are Surging - TipRanks
Harbor Capital Advisors Inc. Takes Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Aberdeen Group plc Trims Stock Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Banque Pictet & Cie SA Purchases Shares of 15,348 Abivax SA Sponsored ADR $ABVX - MarketBeat
ABVX Stock Price, Quote & Chart | ABIVAX SA-ADR (NASDAQ:ABVX) - ChartMill
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Tudor Investment Corp ET AL Acquires New Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Why Abivax SA Sponsored ADR Is Sliding Today - tipranks.com
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Medline (MDLN) and Collegium Pharmaceutical (COLL) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Hudson Bay Capital Management LP Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
35,000 Shares in Abivax SA Sponsored ADR $ABVX Bought by Cantor Fitzgerald L. P. - MarketBeat
Holocene Advisors LP Buys Shares of 461,301 Abivax SA Sponsored ADR $ABVX - MarketBeat
14,000 Shares in Abivax SA Sponsored ADR $ABVX Bought by Bamco Inc. NY - MarketBeat
Europe’s US-Listed ADRs Rose, Led By Solar And Biotech - Finimize
Why Abivax SA Sponsored ADR Is Suddenly Sinking - TipRanks
HighVista Strategies LLC Raises Holdings in Abivax SA Sponsored ADR $ABVX - MarketBeat
805,000 Shares in Abivax SA Sponsored ADR $ABVX Bought by Farallon Capital Management LLC - MarketBeat
First Light Asset Management LLC Purchases Shares of 95,955 Abivax SA Sponsored ADR $ABVX - MarketBeat
713,434 Shares in Abivax SA Sponsored ADR $ABVX Bought by Fairmount Funds Management LLC - MarketBeat
3,164,501 Shares in Abivax SA Sponsored ADR $ABVX Bought by Darwin Global Management Ltd. - MarketBeat
120,000 Shares in Abivax SA Sponsored ADR $ABVX Bought by Boxer Capital Management LLC - MarketBeat
Cantor Fitzgerald L. P. Purchases Shares of 35,000 Abivax SA Sponsored ADR $ABVX - MarketBeat
Boothbay Fund Management LLC Trims Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
Baker BROS. Advisors LP Invests $74.36 Million in Abivax SA Sponsored ADR $ABVX - MarketBeat
Apis Capital Advisors LLC Takes Position in Abivax SA Sponsored ADR $ABVX - Defense World
Melqart Asset Management UK Ltd Invests $5.45 Million in Abivax SA Sponsored ADR $ABVX - MarketBeat
31,000 Shares in Abivax SA Sponsored ADR $ABVX Acquired by Quinn Opportunity Partners LLC - MarketBeat
Why Abivax SA Sponsored ADR Shares Are Sliding - TipRanks
Atika Capital Management LLC Acquires New Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Jefferies Financial Group Inc. Takes Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
TD Asset Management Inc Buys New Shares in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax SA Sponsored ADR (NASDAQ:ABVX) Short Interest Down 13.2% in February - MarketBeat
Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards? - Finviz
Erste Asset Management GmbH Buys New Position in Abivax SA Sponsored ADR $ABVX - MarketBeat
Envestnet Asset Management Inc. Acquires New Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat
Optiver Holding B.V. Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat
Analysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Irhythm Technologies (IRTC) - The Globe and Mail
Greenland Capital Management LP Purchases Shares of 25,039 Abivax SA Sponsored ADR $ABVX - MarketBeat
Patient Square Capital LP Purchases Shares of 151,833 Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax Adr Stock (ABVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):